Neuralink, a company led by Elon Musk, is seeking quadriplegic patients to participate in trials of new brain implants that allow thought-based computer control.
Neuralink's Clinical Trials
Neuralink is looking for quadriplegic patients willing to participate in clinical research. Currently, three patients with such implants are testing devices that track neural activity to control a computer or smartphone under the PRIME study. The study involves people with spinal cord injuries or amyotrophic lateral sclerosis over a six-year period.
Feedback from Neuralink's First Patient
Neuralink's first patient, Noland Arbaugh, reported no adverse effects after a year of using the implant. Arbaugh, who demonstrated computer cursor control through thought, now uses the chip over 10 hours a day and notes that the technology provides hope and purpose.
Future Prospects of Brain Implant Technology
Neuralink's new technologies offer new possibilities for people with disabilities. Elon Musk aims for such implants not only to allow people to operate computers but also to gain 'superpowers.' Patients involved in the trials make a significant contribution to the development of this technology, which might change the lives of thousands in the future.
Neuralink's brain implant technology has the potential to significantly improve the quality of life for people with serious conditions. Clinical trials continue, and initial results are promising.
